Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,575
Closed -$215K 577
2025
Q4
$215K Buy
1,575
+37
+2% +$5.32K 0.01% 486
2025
Q3
$229K Sell
1,538
-14
-0.9% -$1.94K 0.01% 480
2025
Q2
$201K Sell
1,552
-239
-13% -$28.9K 0.01% 466
2025
Q1
$214K Sell
1,791
-11
-0.6% -$1.36K 0.01% 426
2024
Q4
$209K Buy
1,802
+166
+10% +$21K 0.01% 418
2024
Q3
$221K Sell
1,636
-22
-1% -$2.94K 0.01% 387
2024
Q2
$225K Sell
1,658
-55
-3% -$7.48K 0.01% 347
2024
Q1
$221K Buy
+1,713
New +$207K 0.01% 356
2020
Q4
Sell
-67
Closed -$6K 673
2020
Q3
$6K Buy
+67
New +$5.21K ﹤0.01% 504
2020
Q2
Sell
-67
Closed -$4.56K 640
2020
Q1
$4.56K Hold
67
﹤0.01% 499
2019
Q4
$5.45K Sell
67
-4
-6% -$311 ﹤0.01% 567
2019
Q3
$5.29K Buy
+71
New +$5.58K ﹤0.01% 526
2019
Q2
Sell
-4
Closed -$316 668
2019
Q1
$316 Buy
+4
New +$292 ﹤0.01% 719

Other funds holding XYL

Advisory Alpha's XYL Position: Q1 2026 in Review

Advisory Alpha sold out of Xylem (XYL) in Q1 2026, closing a stake of 1,575 shares — an estimated $215K sold.

Advisory Alpha first reported a position in XYL in Q1 2019 and held it in 13 quarters. The position peaked at $229K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Advisory Alpha reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Advisory Alpha sold 1,575 Xylem shares in Q1 2026, an estimated $215K.
  • Advisory Alpha first reported a position in Xylem in Q1 2019 and held it in 13 quarters.
  • Advisory Alpha's Xylem position peaked at $229K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.